FONR · As filed with the SEC

Fonar income statement, by fiscal year

The statement as Fonar presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF OPERATIONS · USD, except per-share amounts

USD, except per-share amounts	FY2025 Year ended Jun 30, 2025	FY2024 Year ended Jun 30, 2024	FY2023 Year ended Jun 30, 2023	FY2022 Year ended Jun 30, 2022	FY2021 Year ended Jun 30, 2021
Revenues
Patient fee revenue – net of contractual allowances and discounts	33,179,446	33,815,796	29,793,993	29,582,238	23,307,389
Product sales	563,296	737,727	731,607	517,939	1,288,483
Service and repair fees	8,234,053	7,452,212	7,419,104	7,590,865	7,638,608
Service and repair fees – related parties	180,000	139,167	110,000	110,000	110,000
Management and other fees	49,900,555	48,789,287	48,640,497	48,226,787	46,609,449
Management and other fees – related medical practices	12,293,968	11,949,900	11,949,900	11,564,316	10,975,836
Total Revenues – Net	104,351,318	102,884,089	98,645,101	97,592,145	89,929,765
Costs and Expenses
Costs related to product sales	1,018,029	1,052,159	852,025	416,814	1,032,676
Costs related to service and repair fees	4,508,518	3,577,570	3,033,967	2,991,069	2,740,625
Costs related to service and repair fees – related parties	323,504	144,413	44,983	43,344	39,466
Cost of Revenue	19,130,935	18,199,579	16,183,166	13,307,819	10,917,635
Costs related to management and other fees	30,073,045	28,626,595	26,975,563	27,251,268	25,384,557
Costs related to management and other fees – related medical practices	6,388,281	6,143,728	5,807,454	6,567,887	6,341,168
Research and Development Expense	1,576,086	1,735,949	1,567,749	1,494,181	1,635,979
Selling, General and Administrative Expense	29,734,163	26,868,732	29,390,932	23,512,581	24,740,044
Total Costs and Expenses	92,752,561	86,348,725	83,855,839	75,584,963	72,832,150
Income from Operations	11,598,757	16,535,364	14,789,262	22,007,182	17,097,615
Interest expense	—	—	(50,131)	(346,552)	(248,665)
Interest expense	(25,611)	(76,997)	—	—	—
Interest income – related party	51,917	25,959	—	—	—
Non-Operating Income (Expense)	2,118,980	2,126,439	1,222,176	247,158	311,931
Other income – related party	0	576,857	—	—	—
Non-Operating Income (Expense)	36,195	78,763	(202,720)	861,087	504,450
Income before Provision for Income Taxes and Noncontrolling Interests	13,780,238	19,266,385	15,758,587	22,768,875	17,665,331
Provision for Income Taxes	(3,106,805)	(5,168,968)	(3,632,071)	(5,534,487)	(3,991,520)
Net Income	—	14,097,417	12,126,516	17,234,388	13,673,811
Consolidated Net Income	10,673,433	—	—	—	—
Net Income – Noncontrolling Interests	(2,339,172)	(3,530,021)	(2,750,740)	(4,793,482)	(3,466,223)
Net Income – Attributable to FONAR	8,334,261	10,567,396	9,375,776	12,440,906	10,207,588
Class A Non Voting Preferred	—	—	—	559,072	458,710
Net Income to Common Shareholders	—	—	—	11,690,796	9,592,134
Common Stockholders	7,802,351	9,908,920	—	—	—
Class A Non Voting Preferred Stockholders	396,443	490,776	—	—	—
Common Class C	135,467	167,700	—	191,038	156,744
Earnings Per Share (Basic)	—	—	—	1.78	1.47
Diluted Net Income Per Common Share Available to Common Stockholders	—	—	—	1.75	1.45
Common Class C	—	—	—	0.50	0.41
Common Stockholders	1.26	1.56	—	—	—
Common Class C	0.35	0.44	—	—	—
Common Stockholders	1.23	1.53	—	—	—
Common Class C	0.35	0.44	—	—	—
Weighted Average Shares Outstanding	—	—	—	6,554,209	6,505,283
Common Stockholders	6,210,852	6,350,862	—	—	—
Common Class C	382,513	382,513	—	—	—
Weighted Average Shares Outstanding, Diluted	—	—	—	6,681,713	6,632,787
Common Class C	—	—	—	382,513	382,513
Common Stockholders	6,338,356	6,478,366	—	—	—
Common Class C	382,513	382,513	—	—	—

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.